A new generation of macrolide antibiotics, it mainly acts on Gram-positive bacteria, anaerobic bacteria, Chlamydia and Mycoplasma, etc. Its in vitro antibacterial effect is similar to that of erythromycin, and its in vivo antibacterial effect is 1 to 4 times stronger than that of erythromycin.

By highly selectively inhibiting the C-14-alpha;-demethylation of fungal cytochrome P-450 sterol, 14-alpha;-methyl sterol accumulates in the fungus, thereby inhibiting the reproduction and growth of the fungus. It has antibacterial activity against Cryptococcus neoformans and Candida species, and is effective against Candida species infections, Cryptococcus neoformans infections, Microsporum and Trichophyton infections, Blastomyces dermatitidis infections, and Coccidioides immitis infections.

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

Mainly stimulates pancreatic β cells to secrete insulin to produce blood sugar lowering effect

It can reduce the production of liver glycogen, reduce intestinal absorption of sugar, and improve insulin sensitivity by increasing peripheral sugar uptake and utilization